Qatar Electrocardiograph (ECG) Market Size and Share
| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 2.04 Million |
| Market Size (2030) | USD 2.73 Million |
| CAGR (2025 - 2030) | 5.71% |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Qatar Electrocardiograph (ECG) Market Analysis by Mordor Intelligence
The Qatar Electrocardiograph Market size is estimated at USD 2.04 million in 2025, and is expected to reach USD 2.73 million by 2030, at a CAGR of 5.71% during the forecast period (2025-2030).
The Qatar electrocardiograph (ECG) market is driven by advancements in healthcare infrastructure and increasing awareness of cardiovascular diseases. The market is influenced by the significant prevalence of heart-related conditions and the growing demand for diagnostic tools to address these health challenges. With a focus on improving healthcare accessibility and quality, Qatar is investing in advanced medical technologies, including ECG devices, to cater to the needs of its population. The market is poised for growth as healthcare providers and policymakers emphasize early diagnosis and preventive care for cardiovascular diseases.
The high prevalence of hypertension and cardiovascular diseases drives the demand for monitoring devices such as ECG. For instance, according to data published by Qatar University in July 2024, approximately 30% of patients aged 25-65 visiting primary healthcare centers in Qatar are diagnosed with hypertension. This high prevalence underscores the need for effective diagnostic tools like ECG devices to monitor and manage cardiovascular health. The growing burden of hypertension and related conditions is expected to fuel the demand for ECG devices in the country.
Additionally, the substantial incidence of coronary artery disease (CAD) among younger individuals drives the demand for ECG devices in Qatar. For instance, an article published by American Hospital Clinics in April 2024 highlighted that cardiologists in Qatar have reported a noticeable increase in heart attacks among younger individuals over the past few years. Furthermore, CAD is increasingly affecting individuals aged 35-45 in Qatar. This trend highlights the need for early diagnosis and monitoring, which is likely to boost the demand for ECG devices as healthcare providers focus on addressing this growing concern.
Furthermore, healthcare providers in Qatar are actively introducing initiatives to improve cardiac care, which is positively impacting the ECG market. For instance, in October 2023, Reyada Medical Centre launched the 'Cardiocare' campaign in conjunction with World Heart Day. This initiative aims to provide comprehensive cardiac care to the community, including affordable cardiac health packages. The 'Heart Prime Care' package, which includes services such as Echocardiogram (ECHO), ECG, CBC, Lipid Profile, and cardiology consultation, highlights the growing emphasis on accessible and cost-effective cardiac diagnostics. Such initiatives are expected to drive the adoption of ECG devices in Qatar.
Therefore, the studied market is positioned for growth, driven by the rising prevalence of cardiovascular diseases, proactive healthcare initiatives, and the increasing incidence of coronary artery disease among younger populations. The integration of affordable and comprehensive cardiac care packages, along with advancements in healthcare infrastructure, is expected to propel the market further.
However, the high cost associated with advanced ECG devices may act as a barrier, potentially limiting the market's expansion in the country during the same period.
Qatar Electrocardiograph (ECG) Market Trends and Insights
Holter ECG Systems Segment is Expected to Have Significant Growth in the Market Over the Forecast Period
The Holter ECG system offers advanced diagnostic solutions for continuous cardiac monitoring. These systems are designed to record a patient’s cardiac activity over extended periods, providing valuable insights into heart health under various conditions. With the significant burden of cardiovascular diseases in Qatar, the demand for such systems has been steadily rising. The segment plays a pivotal role in enabling healthcare providers to deliver precise and comprehensive cardiac care, aligning with the growing focus on improving diagnostic accuracy and patient outcomes in the country.
The significant burden of cardiovascular diseases in Qatar drives the demand for continuous monitoring devices such as Holter ECG systems. For instance, according to data published by the Heart Hospital in October 2023, the number of heart attack cases in Qatar has risen over the past five years. This surge has led to a corresponding increase in diagnostic and interventional cardiac catheterizations, reaching 9,000 cases in 2023. The growing burden of cardiovascular conditions necessitates advanced diagnostic tools like Holter ECG systems, which can provide continuous and precise monitoring, thereby supporting early detection and effective management of heart diseases.
Furthermore, benefits offered by Holter ECG systems, such as extended monitoring durations and enhanced data accuracy, are contributing to their adoption in the Qatar market. For instance, an article published in November 2024 by Norav Medical, a diagnostic solutions company, highlighted the benefits of these systems, which can monitor cardiac activity for periods ranging from 24 hours to 14 days. Patients can wear these devices during daily activities, enabling a comprehensive diagnostic view of their cardiac electrical activity across various states, including sleep, rest, and exercise. This capability ensures precise data collection, which is crucial for accurate diagnosis and treatment planning, thereby driving market growth.
Moreover, supportive initiatives by government and healthcare institutions are further propelling the growth of the Holter ECG systems segment. For instance, in November 2024, Qatar Foundation’s World Innovation Summit for Health (WISH 2024) launched two initiatives aimed at combating obesity, diabetes, and cardiovascular diseases. As part of these efforts, Qatar is set to implement the CARDIO4Cities program, a data-driven approach to addressing cardiovascular health challenges. Such initiatives emphasize the importance of advanced diagnostic tools, including Holter ECG systems, in tackling the rising prevalence of cardiovascular conditions and improving overall healthcare outcomes in the country.
Hence, the segment's growth in the Qatar ECG market is poised to grow over the forecast period, driven by the rising cases of heart attack, benefits offered by Holter systems, and supportive government initiatives.
Aging Population is Expected to Drive the Demand for ECG Devices Over the Forecast Period
The aging population in Qatar is anticipated to drive the demand for electrocardiograph significantly (ECG) devices over the forecast period. With a growing number of older adults requiring advanced healthcare services, the need for effective diagnostic tools like ECG devices is expected to rise. This trend aligns with the increasing prevalence of chronic conditions such as hypertension, diabetes, and cardiovascular diseases among the elderly population, necessitating regular monitoring and early detection of heart-related issues.
The high prevalence of chronic conditions among older adults in Qatar surges the demand for ECG devices. For instance, a study published in August 2024 revealed that 80% of individuals with hypertension, 74.2% with diabetes, and 48.9% with dyslipidemia experienced a higher percentage of falls in Qatar in 2022. These conditions are among the most common comorbidities in individuals aged over 60 years. The increasing burden of such diseases necessitates frequent cardiovascular monitoring, thereby boosting the adoption of ECG devices in the healthcare sector.
Futhermore, the expansion of geriatric care services in Qatar further supports the growth of the ECG market. For instance, according to a document published by the Qatar Foundation in July 2024, Hamad Medical Corporation (HMC) provides geriatric care through a comprehensive service network. This network includes facilities such as Rumailah Hospital, long-term care units, HMC, Heart Hospital, Qatar Rehabilitation Institute, Al Wakrah Hospital, and community-integrated services. The availability of specialized geriatric care infrastructure enhances access to diagnostic tools like ECG devices, meeting the growing healthcare needs of the aging population.
Moreover, awareness programs emphasizing healthy aging also contribute to the increased demand for ECG devices. For instance, in September 2023, Hamad Medical Corporation’s Department of Geriatrics and Long-Term Care, a WHO Collaborating Centre for Healthy Ageing and Dementia, organized events to mark the International Day of Older Persons. These initiatives, conducted in collaboration with HMC’s Heart Hospital, highlighted the importance of preventing heart disease risk factors to ensure healthy aging. Such efforts underscore the critical role of ECG devices in early detection and management of cardiovascular conditions, further driving market growth.
Therefore, Qatar's aging population is expected to significantly impact the electrocardiograph (ECG) market over the forecast period owing to high prevelance of chronic diseases including heart disease, coupled with availability of geriatric healthcare facilties, and awareness initatives for cardiac health.
Competitive Landscape
The competitive landscape of the electrocardiograph (ECG) market in Qatar is characterized by a mix of established companies and emerging players. The market is consolidated yet dynamically competitive. Additionally, many companies offer specialized solutions, contributing to a vibrant and evolving ecosystem. Some of the major players in the market include Koninklijke Philips N.V., Bionet Co., Ltd., SCHILLER, Beurer GmbH, and MEDEL INTERNATIONAL SRL, among others.
Qatar Electrocardiograph (ECG) Industry Leaders
-
Koninklijke Philips N.V.
-
MEDEL INTERNATIONAL SRL
-
Beurer GmbH
-
SCHILLER
-
Bionet Co., Ltd.
- *Disclaimer: Major Players sorted in no particular order
Recent Industry Developments
- January 2025: Hamad Medical Corporation (HMC) introduced the first Neurocardiac Rehabilitation Program in Qatar and the region. This initiative is designed to assist patients with both cardiac and neurological conditions. Using advanced diagnostic and therapeutic tools, including telemetry, ECG analysis, exercise testing, tailored exercise prescriptions, dosage calculations, and advanced screening techniques, the program provides personalized treatment plans to enhance patient recovery and long-term health.
- April 2024: Hamad Medical Corporation (HMC) collaborated with ConocoPhillips for the Kulluna Healthy Heart campaign in Qatar. As part of the FestivalCares CSR program, this initiative focuses on promoting heart health and improving community wellbeing. The campaign provides free comprehensive health tests, including assessments of blood cholesterol, glucose levels, blood pressure, and Body Mass Index (BMI).
Qatar Electrocardiograph (ECG) Market Report Scope
As per the scope of the report, an electrocardiograph (ECG) is a medical device used to record the heart's electrical activity. The device captures the heart's electrical signals and produces a graphical representation known as an electrocardiogram.
The Qatar electrocardiograph (ECG) market report provides a comprehensive analysis of the current state and growth potential of the ECG market in the country. The Qatar ECG market is segmented by product type, which includes resting (12-lead ECG) systems, stress ECG systems, Holter ECG systems, and ECG management software. The report offers the market size in terms of both value (in USD) and volume (in units) for the above segments.
| Resting (12-Lead ECG) Systems |
| Stress ECG Systems |
| Holter ECG Systems |
| ECG Management Software |
| By Product Type | Resting (12-Lead ECG) Systems |
| Stress ECG Systems | |
| Holter ECG Systems | |
| ECG Management Software |
Key Questions Answered in the Report
How big is the Qatar Electrocardiograph Market?
The Qatar Electrocardiograph Market size is expected to reach USD 2.04 million in 2025 and grow at a CAGR of 5.71% to reach USD 2.73 million by 2030.
What is the current Qatar Electrocardiograph Market size?
In 2025, the Qatar Electrocardiograph Market size is expected to reach USD 2.04 million.
Who are the key players in Qatar Electrocardiograph Market?
Koninklijke Philips N.V., MEDEL INTERNATIONAL SRL, Beurer GmbH, SCHILLER and Bionet Co., Ltd. are the major companies operating in the Qatar Electrocardiograph Market.
What years does this Qatar Electrocardiograph Market cover, and what was the market size in 2024?
In 2024, the Qatar Electrocardiograph Market size was estimated at USD 1.92 million. The report covers the Qatar Electrocardiograph Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Qatar Electrocardiograph Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Page last updated on:
Qatar Electrocardiograph (ECG) Market Report
Statistics for the 2025 Qatar Electrocardiograph (ECG) market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Qatar Electrocardiograph (ECG) analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
